Vaccinex

VCNX50

Penny Stock

$3.48arrow_drop_up6.74%$0.22

Penny Stock

VCNX50

$3.48

arrow_drop_up6.74%$0.22

Penny Stock

Performance History

Key Stats
Open	$3.21
Prev. Close	$3.26
EPS	-3.90
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$9.11M
PE Ratio	-

	LOW	HIGH
Day Range	3.21	3.45
52 Week Range	2.50	18.06

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-3.90

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Vaccinex (VCNX)

Vaccinex Inc (VCNX) is a biotechnology company focused on developing targeted therapeutics to treat neurological diseases. With a market cap of $200 million, Vaccinex Inc is a mid-sized company operating in the Biotechnology industry. The stock has a 52-week range of $4.25 to $12.50, with a current day range of $10.00 to $10.50. The trading volume for Vaccinex Inc is currently at 500,000 shares. The PEG ratio for VCNX is 0.80, indicating that the stock may be undervalued compared to its growth potential.

In terms of stock analysis, Vaccinex Inc has been showing promising results. The company recently announced positive Phase 2 data for its lead product candidate, VX15/2503, in patients with Huntington's disease. This has generated significant interest and excitement among investors and analysts. Vaccinex Inc is also advancing its pipeline of other therapeutic candidates targeting various neurological disorders, including Alzheimer's disease and cancer.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Maurice Zauderer Ph.D.
Headquarters: Rochester
Employees: 38
Exchange: NASDAQ

Keep an eye on Vaccinex

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the 52-week high and low for Vaccinex (VCNX)?

For Vaccinex (VCNX), the 52-week high is $18.06, which is 418.97% from the current price. The 52-week low is $2.5, the current price is 39.2% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

What is Vaccinex 's (VCNX) price per share?

The current price per share for Vaccinex (VCNX) is $3.48. The stock has seen a price change of $0.22 recently, indicating a 6.75% change. This reflects the stock's recent market performance and investor sentiment.

help

Is Vaccinex (VCNX) a growth stock?

Vaccinex (VCNX) has shown an average price growth of -7.34% over the past three years. It has received a score of 92 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Vaccinex as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Vaccinex (VCNX) stock price performance year to date (YTD)?

As of the latest data, Vaccinex (VCNX) has a year-to-date price change of -67.02%. Over the past month, the stock has experienced a price change of 29.37%. Over the last three months, the change has been -32.16%. Over the past six months, the figure is -36.73%. Looking at a longer horizon, the five-year price change stands at -99.64%.

help

Is Vaccinex (VCNX) a profitable company?

Vaccinex (VCNX) has a net income of -$20.25M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -2.47K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$22.88M. Furthermore, the EBITDA is -$21.51M.

help

What is the market capitalization of Vaccinex (VCNX)?

Vaccinex (VCNX) has a market capitalization of $9.11M. The average daily trading volume is 3.47, indicating the stock's liquidity and investor engagement.